252 related articles for article (PubMed ID: 18223018)
1. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
Hoffmann LA; Jarius S; Pellkofer HL; Schueller M; Krumbholz M; Koenig F; Johannis W; la Fougere C; Newman T; Vincent A; Voltz R
J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):767-73. PubMed ID: 18223018
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
[TBL] [Abstract][Full Text] [Related]
3. Clinical analysis of anti-Ma2-associated encephalitis.
Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
5. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
6. Hu, Yo, Ri, Ma, Ta: monosyllabic answers to complex questions.
Verschuuren J
J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):742. PubMed ID: 18559456
[No Abstract] [Full Text] [Related]
7. Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.
Ortega Suero G; Sola-Valls N; Escudero D; Saiz A; Graus F
Neurologia (Engl Ed); 2018; 33(1):18-27. PubMed ID: 27460184
[TBL] [Abstract][Full Text] [Related]
8. Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.
Vogrig A; Joubert B; Maureille A; Thomas L; Bernard E; Streichenberger N; Cotton F; Ducray F; Honnorat J
J Neurol; 2019 Feb; 266(2):398-410. PubMed ID: 30498914
[TBL] [Abstract][Full Text] [Related]
9. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ta-associated paraneoplastic encephalitis with occult testicular intratubular germ-cell neoplasia.
Prüss H; Voltz R; Flath B; Rudolph B; Klingebiel R; Zschenderlein R; Prass K
J Neurol Neurosurg Psychiatry; 2007 Jun; 78(6):651-2. PubMed ID: 17507450
[No Abstract] [Full Text] [Related]
11. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.
Graus F; Keime-Guibert F; Reñe R; Benyahia B; Ribalta T; Ascaso C; Escaramis G; Delattre JY
Brain; 2001 Jun; 124(Pt 6):1138-48. PubMed ID: 11353730
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
Dalmau J; Porta-Etessam J
Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
[TBL] [Abstract][Full Text] [Related]
13. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
14. Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin.
Kimura M; Onozawa M; Fujisaki A; Arakawa T; Takeda K; Dalmau J; Hattori K
Int J Urol; 2008 Oct; 15(10):942-3. PubMed ID: 19138287
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic neurological syndromes in 2008].
Honnorat J
Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies in Paraneoplastic Neurological Syndrome].
Kawachi I
Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
[TBL] [Abstract][Full Text] [Related]
17. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
18. Mesothelioma and anti-Ma paraneoplastic syndrome; heterogeneity in immunogenic tumours increases.
Archer HA; Panopoulou A; Bhatt N; Edey AJ; Giffin NJ
Pract Neurol; 2014 Feb; 14(1):33-5. PubMed ID: 23749880
[TBL] [Abstract][Full Text] [Related]
19. [Paraneoplastic neurological syndrome associated with anti-Ma2 antibodies].
Khammassi N; Balhouane I; Gargouri A; Gouider R; Cherif O
Rev Neurol (Paris); 2012 Feb; 168(2):192-3. PubMed ID: 21962240
[No Abstract] [Full Text] [Related]
20. Cerebrospinal fluid study in paraneoplastic syndromes.
Psimaras D; Carpentier AF; Rossi C;
J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):42-5. PubMed ID: 19324868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
